Novo submits high-dose Wegovy for FDA approval using voucher / Endpoints

Max Bayer / endpoints - Novo Nordisk submitted a higher dose of its obesity drug Wegovy for FDA approval and is using a recently-won voucher to expedite the review. The company said Wednesday that it submitted ...

#obesity #healthcare #pharmaceuticals #novonordisk #weightloss #publichealth #biotech #drugdevelopment #fda

Novo Nordisk seeks FDA approval of higher-dose Wegovy

3 months / beckershospitalreview / Paige Twenter

Novo submits high-dose Wegovy for FDA approval using voucher

3 months / endpoints / Max Bayer

Saturday, November 29, 2025, 5:21 pm / permalink 16400 / 2 stories in 3 months

CASSANDRA-PACT-21 Trial Update: Preoperative PAXG vs mFOLFIRINOX in Resectable and Borderline Resectable PDAC / OncoDaily

oncodaily - The landscape of early-stage pancreatic ductal adenocarcinoma (PDAC) continues to evolve as clinicians move from surgery-first strategies toward perioperative treatment. Neoadjuvant and perioperative approaches have shown growing promise, yet no […]

#healthcare #pharmaceuticals #publichealth #drugdevelopment

Advancing and Learning More About New Treatments for Pancreatic Cancer Every Day – Dana-Farber Cancer Institute

3 months / oncodaily

Yan Leyfman: New Advances in Pancreatic Cancer Immunotherapy

3 months / oncodaily

Allogeneic Stem Cell–Engineered Mesothelin-Redirected CAR-NKT Cells for Orthotopic and Metastatic Pancreatic Cancer

3 months / oncodaily

CASSANDRA-PACT-21 Trial Update: Preoperative PAXG vs mFOLFIRINOX in Resectable and Borderline Resectable PDAC

3 months / oncodaily

Neoadjuvant Quadruplet PAXG Regimen Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable PDAC

3 months / esmo

Saturday, November 29, 2025, 9:21 am / permalink 16387 / 5 stories in 3 months

Tracking with care: The ethics of using location tracking technology with people living with dementia / Medical Express

medicalxpress - Imagine you're 83 years old, living with dementia in a long-term care home. Lately, your caregivers keep asking you to wear a bracelet on your wrist 24/7. They say it's for your safety, so they can locate you quickly when needed.

#healthcare #publichealth

Tracking with care: The ethics of using location tracking technology with people living with dementia

3 months / medicalxpress

Tracking with care: The ethics of using location tracking technology with people living with dementia

3 months / theconversation / Madalena Pamela Liougas, PhD Candidate, Rehabilitation Science Institute, University of Toronto

Saturday, November 29, 2025, 5:21 am / permalink 16384 / 2 stories in 3 months

StackHealth Time Machine

Outgoing Stories

HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours

Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours

Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours

Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours

FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours

HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours

Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours

Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours

Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours

AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours

More StackHealth

Bluesky: